Circulatory Support Devices Market Size, Share and Growth Outlook, 2026

Circulatory Support Devices Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Circulatory Support Devices Market size is forecast to increase from $3.93 Billion in 2026 to $7.95 Billion in 2034 at a CAGR of 9.2% between 2026 and 2034.

The Circulatory Support Devices market report provides detailed analysis and outlook of Circulatory Support Devices segments including By Product Type (Ventricular Assist Devices, Intra-Aortic Balloon Pumps, Extracorporeal Membrane Oxygenation Systems, Total Artificial Hearts ), By System Modality (Implantable Circulatory Support Systems, Percutaneous ), By Patient Application (Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, Cardiogenic Shock and Acute Myocardial Infarction Management), By End-User (Hospitals and Specialized Cardiac Centers, Ambulatory Surgical Centers, Specialty Outpatient Clinics) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Circulatory Support Devices Industry Overview

Advanced Mechanical Circulatory Support Technologies Driving Industry Evolution

The circulatory support devices industry continues to advance as healthcare providers seek effective solutions for managing severe heart failure, cardiogenic shock, and end-stage cardiovascular disease. Mechanical circulatory support systems play a critical role in stabilizing patients awaiting transplantation, supporting recovery from acute cardiac events, and providing long-term assistance for individuals with advanced ventricular dysfunction. Ongoing innovation is focused on improving device durability, reducing complications, enhancing patient outcomes, and expanding treatment options for increasingly complex cardiovascular conditions. Technological advancements in ventricular assist devices, temporary support systems, and artificial heart technologies are reshaping the landscape of advanced cardiac care.

HeartMate 3 Strengthening Long-Term Ventricular Assist Device Adoption

A major trend within the circulatory support devices market is the continued expansion of advanced left ventricular assist device technologies. Abbott remains focused on broadening the clinical adoption of its HeartMate 3 platform, which has demonstrated strong performance in long-term mechanical circulatory support applications. Recent clinical documentation highlights the device’s ability to reduce adverse events, particularly pump thrombosis, when compared with earlier-generation ventricular assist systems. These improvements have reinforced the HeartMate 3 platform’s position as a leading standard for durable mechanical circulatory support. Enhanced hemocompatibility, improved blood flow dynamics, and reduced complication rates are contributing to increased physician confidence and broader utilization among patients with advanced heart failure.

AI-Driven Hemodynamic Monitoring Enhancing Cardiogenic Shock Management

Temporary circulatory support technologies continue to evolve through integration with advanced monitoring capabilities. Abiomed, part of Johnson & Johnson, continues to report strong clinical utilization of its Impella product portfolio for the treatment of cardiogenic shock and high-risk cardiac interventions. Current research and development initiatives are focused on optimizing device placement techniques and refining monitoring algorithms that support individualized patient management. A growing emphasis on artificial intelligence-driven hemodynamic monitoring is enabling clinicians to better assess circulatory status, guide therapy adjustments, and improve decision-making during critical care interventions. These innovations are helping maximize the clinical effectiveness of temporary mechanical support systems in acute cardiovascular settings.

Total Artificial Heart Development Expanding Future Treatment Possibilities

The pursuit of viable long-term total artificial heart technologies remains an important area of innovation within the circulatory support devices industry. Companies such as BiVACOR are progressing through clinical evaluations of titanium-based, magnetically levitated pump systems designed to replace the complete pumping function of the human heart. These technologies target patients with biventricular failure who may not be candidates for conventional ventricular assist devices. By utilizing mag-lev pump architectures, developers aim to reduce mechanical wear, improve durability, and support continuous blood flow. Ongoing clinical studies are evaluating the ability of these next-generation total artificial heart systems to provide reliable long-term circulatory support for patients with severe cardiac dysfunction.

Circulatory Support Devices Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Circulatory Support Devices market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Abbott Laboratories, Medtronic plc, Abiomed (Johnson & Johnson), Getinge AB, Berlin Heart GmbH, Terumo Corporation, Teleflex Incorporated, LivaNova plc, Jarvik Heart, Inc., SynCardia Systems, LLC. The Circulatory Support Devices market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Circulatory Support Devices industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Circulatory Support Devices Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Circulatory Support Devices companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Circulatory Support Devices markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Circulatory Support Devices Market Competitive Benchmarking and Company Analysis

Leading companies in Circulatory Support Devices industry include- Abbott Laboratories, Medtronic plc, Abiomed (Johnson & Johnson), Getinge AB, Berlin Heart GmbH, Terumo Corporation, Teleflex Incorporated, LivaNova plc, Jarvik Heart, Inc., SynCardia Systems, LLC. The Circulatory Support Devices market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Circulatory Support Devices Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Circulatory Support Devices market remains one of the strongest-performing segments in the country.
The US Circulatory Support Devices Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Circulatory Support Devices market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Circulatory Support Devices industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Circulatory Support Devices markets

Canada's strong Circulatory Support Devices sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Circulatory Support Devices market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Circulatory Support Devices Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Circulatory Support Devices market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Circulatory Support Devices population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Circulatory Support Devices industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Circulatory Support Devices market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Circulatory Support Devices sales through 2034

France Circulatory Support Devices companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Circulatory Support Devices Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Circulatory Support Devices distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Circulatory Support Devices Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Circulatory Support Devices market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Circulatory Support Devices industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Circulatory Support Devices industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Circulatory Support Devices Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Circulatory Support Devices market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Circulatory Support Devices market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Circulatory Support Devices Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Circulatory Support Devices Market Segmentation

By Product Type
Ventricular Assist Devices
Intra-Aortic Balloon Pumps
Extracorporeal Membrane Oxygenation Systems
Total Artificial Hearts
By System Modality
Implantable Circulatory Support Systems
Percutaneous
By Patient Application
Bridge-to-Transplant
Destination Therapy
Bridge-to-Recovery
Cardiogenic Shock and Acute Myocardial Infarction Management
By End-User
Hospitals and Specialized Cardiac Centers
Ambulatory Surgical Centers
Specialty Outpatient Clinics

Top Companies in Circulatory Support Devices Industry

Abbott Laboratories
Medtronic plc
Abiomed (Johnson & Johnson)
Getinge AB
Berlin Heart GmbH
Terumo Corporation
Teleflex Incorporated
LivaNova plc
Jarvik Heart, Inc.
SynCardia Systems, LLC

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025